CN100556472C - 分离性输血-设备 - Google Patents
分离性输血-设备 Download PDFInfo
- Publication number
- CN100556472C CN100556472C CNB2004800303263A CN200480030326A CN100556472C CN 100556472 C CN100556472 C CN 100556472C CN B2004800303263 A CNB2004800303263 A CN B2004800303263A CN 200480030326 A CN200480030326 A CN 200480030326A CN 100556472 C CN100556472 C CN 100556472C
- Authority
- CN
- China
- Prior art keywords
- column
- app
- amyloid
- apheresis
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cardiology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ATA1444/2003 | 2003-09-12 | ||
| AT0144403A AT413336B (de) | 2003-09-12 | 2003-09-12 | Apherese-vorrichtung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1867365A CN1867365A (zh) | 2006-11-22 |
| CN100556472C true CN100556472C (zh) | 2009-11-04 |
Family
ID=34280361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004800303263A Expired - Fee Related CN100556472C (zh) | 2003-09-12 | 2004-09-13 | 分离性输血-设备 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7935252B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1663347B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4509113B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN100556472C (cg-RX-API-DMAC7.html) |
| AT (2) | AT413336B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004271651B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2538305C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1107911T1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE502004005851D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1663347T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2298789T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20080090T3 (cg-RX-API-DMAC7.html) |
| PL (1) | PL1663347T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1663347E (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005025651A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003303198A1 (en) | 2002-12-19 | 2004-07-14 | New York University | Method for treating amyloid disease |
| AT500483B1 (de) | 2004-07-13 | 2006-01-15 | Mattner Frank Dr | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
| AT501621A1 (de) * | 2005-03-15 | 2006-10-15 | Mattner Frank Dr | Zusammensetzungen zur verwendung bei der vorbeugung und behandlung der alzheimer- erkrankung |
| ES2332846B1 (es) * | 2007-10-26 | 2010-07-08 | Grifols, S.A. | Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos. |
| EP2237804B1 (en) * | 2007-12-21 | 2013-04-10 | GE Healthcare Bio-Sciences AB | Method for sterilization of chemically activated solid support materials |
| US20100030196A1 (en) * | 2008-07-29 | 2010-02-04 | Medtronic, Inc. | Apheresis of a target molecule from cerebrospinal fluid |
| US20100158893A1 (en) * | 2008-12-19 | 2010-06-24 | Baxter International Inc. | Systems and methods for obtaining immunoglobulin from blood |
| CN102264411B (zh) * | 2008-12-22 | 2014-10-22 | 学校法人藤田学园 | Aβ除去材料、Aβ除去器和Aβ除去系统 |
| US20110033463A1 (en) * | 2009-08-06 | 2011-02-10 | Medtronic, Inc. | Apheresis, administration of agent, or combination thereof |
| EP2497828A1 (en) * | 2011-03-07 | 2012-09-12 | Charité - Universitätsmedizin Berlin | Use of aptamers in therapy and/or diagnosis of autoimmune diseases |
| RS53496B1 (sr) | 2011-10-04 | 2015-02-27 | Affiris Ag | POSTUPAK ZA DETEKCIJU Aβ-SPECIFIČNIH ANTITELA U BIOLOŠKOM UZORKU |
| US9717841B2 (en) | 2012-09-11 | 2017-08-01 | Gary L. McNeil | Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source |
| EP3166660B1 (en) * | 2014-07-10 | 2017-12-13 | Affiris AG | Substances and methods for the use in prevention and/or treatment in huntington's disease |
| JP6876601B2 (ja) | 2014-07-10 | 2021-05-26 | アフィリス・アクチェンゲゼルシャフトAffiris Ag | ハンチントン病の予防および/または処置における使用のための物質および方法 |
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| KR20210124308A (ko) | 2019-01-30 | 2021-10-14 | 트루바인딩 아이엔씨. | 항-gal3 항체 및 이의 용도 |
| GB201904810D0 (en) * | 2019-04-05 | 2019-05-22 | Cynapsedx Ltd | The treatment of protein aggregation diseases |
| MX2022014786A (es) | 2020-05-26 | 2023-01-16 | Truebinding Inc | Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3. |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4409105A (en) * | 1980-12-18 | 1983-10-11 | Asahi Kasei Kogyo Kabushiki Kaisha | Dried, sterilized, gamma-globulin-fixed column and a process for preparing the same |
| US4770774A (en) * | 1985-09-19 | 1988-09-13 | Toray Industries, Inc. | Column for removing β2 -microglobulin |
| US5216127A (en) * | 1987-11-20 | 1993-06-01 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Adsorbent for serum amyloid protein |
| WO2003051374A2 (en) * | 2001-12-17 | 2003-06-26 | New York State Office Of Mental Health | SEQUESTRATION OF Aβ IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES |
| WO2004056318A2 (en) * | 2002-12-19 | 2004-07-08 | New York University | Method for treating amyloid disease |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3880647T2 (de) * | 1987-11-20 | 1993-11-18 | Kanegafuchi Chemical Ind | Sorbentmittel für Serum-Amyloid-Proteine. |
| JPH01171638A (ja) * | 1987-12-25 | 1989-07-06 | Kanegafuchi Chem Ind Co Ltd | 血清アミロイドa蛋白用吸着体 |
| US5604102A (en) * | 1992-04-15 | 1997-02-18 | Athena Neurosciences, Inc. | Methods of screening for β-amyloid peptide production inhibitors |
| JPH06104122A (ja) | 1992-09-21 | 1994-04-15 | Matsushita Electric Ind Co Ltd | ロータリートランス |
| AU691297B2 (en) * | 1994-05-13 | 1998-05-14 | Miltenyi Biotec Gmbh | Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood |
| DE19515554C2 (de) * | 1995-04-27 | 1999-06-17 | Braun Melsungen Ag | Verwendung eines Mittels und Vorrichtung zur simultanen extrakorporalen Elimination von Tumor-Nekrose-Faktor alpha und bakteriellen Lipopolysacchariden aus Vollblut oder/und Blutplasma |
| US5868936A (en) * | 1996-06-20 | 1999-02-09 | Baxter International Inc. | Affinity membrane system and method of using same |
| US6787523B1 (en) * | 1997-12-02 | 2004-09-07 | Neuralab Limited | Prevention and treatment of amyloidogenic disease |
| EA006606B1 (ru) | 2000-02-24 | 2006-02-24 | Вашингтон Юниверсити | Гуманизированное антитело и его фрагмент, взаимодействующие с бета-амилоидным пептидом, и способы их применения |
| TWI238251B (en) * | 2000-07-13 | 2005-08-21 | Anawrhta Biotech Co Ltd | In-vitro adsorbing device using immunity |
| AT413945B (de) * | 2003-01-14 | 2006-07-15 | Mattner Frank Dr | Impfstoff für die alzheimer-krankheit |
| AT413946B (de) * | 2004-07-13 | 2006-07-15 | Mattner Frank Dr | Impfstoff gegen die alzheimer-krankheit |
| AT500835B1 (de) * | 2004-09-13 | 2007-12-15 | Affiris Forschungs & Entwicklungs Gmbh | Cholinestertransport-protein-mimotop als atherosklerose-medikament |
-
2003
- 2003-09-12 AT AT0144403A patent/AT413336B/de not_active IP Right Cessation
-
2004
- 2004-09-13 PL PL04761033T patent/PL1663347T3/pl unknown
- 2004-09-13 PT PT04761033T patent/PT1663347E/pt unknown
- 2004-09-13 DK DK04761033T patent/DK1663347T3/da active
- 2004-09-13 US US10/571,469 patent/US7935252B2/en not_active Expired - Fee Related
- 2004-09-13 AU AU2004271651A patent/AU2004271651B2/en not_active Ceased
- 2004-09-13 WO PCT/AT2004/000311 patent/WO2005025651A1/de not_active Ceased
- 2004-09-13 JP JP2006525566A patent/JP4509113B2/ja not_active Expired - Fee Related
- 2004-09-13 CA CA2538305A patent/CA2538305C/en not_active Expired - Fee Related
- 2004-09-13 AT AT04761033T patent/ATE382383T1/de active
- 2004-09-13 CN CNB2004800303263A patent/CN100556472C/zh not_active Expired - Fee Related
- 2004-09-13 EP EP04761033A patent/EP1663347B1/de not_active Expired - Lifetime
- 2004-09-13 ES ES04761033T patent/ES2298789T3/es not_active Expired - Lifetime
- 2004-09-13 DE DE502004005851T patent/DE502004005851D1/de not_active Expired - Lifetime
- 2004-09-13 HR HR20080090T patent/HRP20080090T3/xx unknown
-
2008
- 2008-03-21 CY CY20081100330T patent/CY1107911T1/el unknown
-
2011
- 2011-03-17 US US13/049,994 patent/US20110166327A1/en not_active Abandoned
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4409105A (en) * | 1980-12-18 | 1983-10-11 | Asahi Kasei Kogyo Kabushiki Kaisha | Dried, sterilized, gamma-globulin-fixed column and a process for preparing the same |
| US4770774A (en) * | 1985-09-19 | 1988-09-13 | Toray Industries, Inc. | Column for removing β2 -microglobulin |
| US5216127A (en) * | 1987-11-20 | 1993-06-01 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Adsorbent for serum amyloid protein |
| WO2003051374A2 (en) * | 2001-12-17 | 2003-06-26 | New York State Office Of Mental Health | SEQUESTRATION OF Aβ IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES |
| WO2004056318A2 (en) * | 2002-12-19 | 2004-07-08 | New York University | Method for treating amyloid disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2538305C (en) | 2011-05-24 |
| HRP20080090T3 (hr) | 2008-03-31 |
| ATA14442003A (de) | 2005-07-15 |
| US20110166327A1 (en) | 2011-07-07 |
| DE502004005851D1 (de) | 2008-02-14 |
| EP1663347A1 (de) | 2006-06-07 |
| JP4509113B2 (ja) | 2010-07-21 |
| AT413336B (de) | 2006-02-15 |
| US20070026029A1 (en) | 2007-02-01 |
| ES2298789T3 (es) | 2008-05-16 |
| EP1663347B1 (de) | 2008-01-02 |
| HK1096320A1 (zh) | 2007-06-01 |
| CA2538305A1 (en) | 2005-03-24 |
| CY1107911T1 (el) | 2013-09-04 |
| CN1867365A (zh) | 2006-11-22 |
| DK1663347T3 (da) | 2008-05-19 |
| JP2007504863A (ja) | 2007-03-08 |
| US7935252B2 (en) | 2011-05-03 |
| PT1663347E (pt) | 2008-03-28 |
| AU2004271651B2 (en) | 2009-08-06 |
| WO2005025651A1 (de) | 2005-03-24 |
| PL1663347T3 (pl) | 2008-06-30 |
| AU2004271651A1 (en) | 2005-03-24 |
| ATE382383T1 (de) | 2008-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20110166327A1 (en) | Apheresis device | |
| AU2005261687B8 (en) | Combination therapy for the prevention or treatment of Alzheimer's disease as well as kit therefor | |
| US20060030027A1 (en) | Capture and removal of biomolecules from body fluids using partial molecular imprints | |
| CN101443041A (zh) | 治疗炎性肠病的方法和装置 | |
| EP0313378A2 (en) | Methods and compositions for transient elimination of humoral immune antibodies | |
| US20220143291A1 (en) | Whole blood treatment device and methods of removing target agents from whole blood | |
| EP2361645B1 (en) | Use of a carrier for removal amyloid beta protein from extracorporeal fluids | |
| US6080404A (en) | Materials and methods for removal of substances from fluids | |
| CN114929338A (zh) | 通过靶向内源性调控因子增强血脑屏障药物转运 | |
| Weiss et al. | The impact of citrate concentration on adhesion of platelets and leukocytes to adsorbents in whole blood lipoprotein apheresis | |
| KR101139103B1 (ko) | 아페레시스 장치 | |
| Schossee et al. | Profile of the single‐use, multiple‐pass protein A adsorber column in immunoadsorption | |
| HK1096320B (zh) | 分离性输血-设备 | |
| JP7255899B2 (ja) | 組織または流体から分子を選択的に除去するためのデバイス | |
| WO2007111969A2 (en) | C-reactive protein apheresis | |
| WO2005025650A1 (de) | Apherese-vorrichtung | |
| US9708372B2 (en) | Agonistic autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in Alzheimer's and vascular dementia | |
| US20180303998A1 (en) | Novel Treatment Method for Cockayne Syndrome | |
| Azhari et al. | Specific removal of paraquat by hemoperfusion through antiparaquat conjugated agarose‐polyacrolein microsphere beads | |
| US20200291101A1 (en) | Novel Treatment Method for Cockayne Syndrome | |
| JPH0611335B2 (ja) | 吸着体および除去装置 | |
| HK1243715B (en) | Preparation and composition of inter-alpha inhibitor proteins from blood |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1096320 Country of ref document: HK |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1096320 Country of ref document: HK |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091104 Termination date: 20160913 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |